Orthofix Medical Inc. (OFIX)

Orthofix Medical Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	818.06	799.49	746.64	460.71	464.48	406.56
Revenue Growth (YoY)	4.31%	7.08%	62.06%	-0.81%	14.25%	-11.61%
Cost of Revenue	253.45	241.42	224.32	123.54	114.91	101.89
Gross Profit	564.61	558.07	522.32	337.17	349.57	304.67
Selling, General & Admin	554.06	532.53	530.4	308.78	290.67	272.38
Research & Development	69.28	73.64	80.23	49.07	49.62	39.06
Amortization of Goodwill & Intangibles	15.59	17.44	17.46	9.8	9.41	6.8
Operating Expenses	638.93	623.6	628.08	367.64	349.7	318.24
Operating Income	-74.32	-65.53	-105.77	-30.47	-0.13	-13.57
Interest Expense	-28.06	-29.63	-8.63	-1.29	-1.84	-2.48
Currency Exchange Gain (Loss)	-4.4	-5.02	2.59	-3.29	-3.98	-
Other Non Operating Income (Expenses)	7.93	1.18	-2	0.32	0.33	8.38
EBT Excluding Unusual Items	-98.84	-99.01	-113.81	-34.72	-5.62	-7.67
Merger & Restructuring Charges	-6.09	-12.19	-36.04	-	-	-
Impairment of Goodwill	-	-	-	-	-11.76	-
Gain (Loss) on Sale of Investments	-0.41	-5.78	-1.52	-0.18	0.31	-
Other Unusual Items	1.11	-6.9	2.7	17.2	3.58	7.3
Pretax Income	-118.33	-123.88	-148.68	-17.71	-13.5	-0.37
Income Tax Expense	0.79	2.12	2.72	2.04	24.88	-2.89
Earnings From Continuing Operations	-119.12	-126	-151.4	-19.75	-38.38	2.52
Net Income	-119.12	-126	-151.4	-19.75	-38.38	2.52
Net Income to Common	-119.12	-126	-151.4	-19.75	-38.38	2.52
Shares Outstanding (Basic)	39	38	37	20	20	19
Shares Outstanding (Diluted)	39	38	37	20	20	19
Shares Change (YoY)	4.07%	3.82%	83.16%	1.84%	1.54%	2.58%
EPS (Basic)	-3.03	-3.30	-4.12	-0.98	-1.95	0.13
EPS (Diluted)	-3.03	-3.30	-4.12	-0.98	-1.95	0.13
Free Cash Flow	-2.9	-9.09	-107.8	-34.7	0.69	51.55
Free Cash Flow Per Share	-0.07	-0.24	-2.94	-1.73	0.04	2.66
Gross Margin	69.02%	69.80%	69.96%	73.18%	75.26%	74.94%
Operating Margin	-9.09%	-8.20%	-14.17%	-6.61%	-0.03%	-3.34%
Profit Margin	-14.56%	-15.76%	-20.28%	-4.29%	-8.26%	0.62%
Free Cash Flow Margin	-0.35%	-1.14%	-14.44%	-7.53%	0.15%	12.68%
EBITDA	0.25	10.43	-45.21	1.61	32.96	20.71
EBITDA Margin	0.03%	1.31%	-6.05%	0.35%	7.10%	5.09%
D&A For EBITDA	74.57	75.96	60.56	32.08	33.1	34.28
EBIT	-74.32	-65.53	-105.77	-30.47	-0.13	-13.57
EBIT Margin	-9.09%	-8.20%	-14.16%	-6.61%	-0.03%	-3.34%
Advertising Expenses	-	-	-	-	0.5	0.9

Updated Nov 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q